Skip to main content

Table 1 Different NFATC1 forms and mutants used in the experiments

From: Phosphorylation of NFATC1 at PIM1 target sites is essential for its ability to promote prostate cancer cell migration and invasion

NFATC1 proteins

Mutated sites

Length

Wild type (WT)

none

full-length

Dominant negative (DN)

none

410–680 aa

Constitutively active (mSRR)

all 11 serines mutated to alanines in the SRR (172–194)

1–418 aa

Double mutant (DM)

S245, S269

full-length

Triple mutant (TM)

S151, S153, T154, S256, S257, S335, T338, T339

full-length

Multi mutant (MM)

S151, S153, T154, S245, S256, S257, S269, S335, T338, T339

full-length

  1. The amino acid substitutions (from serine or threonine to alanine) and other mutations in NFATC1 and the length of each mutant protein used in this study